We are committed to conducting our business with integrity and the pursuit of excellence in all that we do. Our management team and our Board of Directors are committed to honesty and compliance with all laws, rules, regulations and corporate policies that apply to our business, and we expect the same commitment from our employees, consultants, business partners and service providers. In particular, we are committed to acting responsibly, safely and with transparency in our interactions with patients, doctors and other stakeholders in the healthcare system.
Everything we do at Jazz is focused on three things: Putting patients first, being a great place to work and living our values:
Integrity • Collaboration • Passion • Innovation • Pursuit of Excellence
To email us: firstname.lastname@example.org
To write to us: Jazz Pharmaceuticals plc
c/o Jazz Pharmaceuticals, Inc.
3170 Porter Drive
Palo Alto, CA 94304
Attn: Chief Compliance Officer
Compliance with applicable laws, rules and regulations in the countries where we do business is an overriding principle of Jazz Pharmaceuticals’ corporate culture. The company’s commitment to ethical behavior is implemented through comprehensive compliance policies, employee training and monitoring programs and an open-door policy for reporting suspected violations. Read more about our Compliance Program below.
As part of Jazz Pharmaceuticals’ continuing commitment to corporate compliance, Jazz Pharmaceuticals declares that, to the best of its knowledge, and based on a good faith understanding of the statutory requirements of California Health and Safety Code § 119400 and 119402, it has adopted a Comprehensive Compliance Program as mandated by this California law. To the best of our knowledge, as of July 1, 2023, Jazz Pharmaceuticals believes that it is in compliance with its Comprehensive Compliance Program and its good faith understanding of the requirements of California Health and Safety Code § 119400 and 119402.
For questions about our Comprehensive Compliance Program or to obtain a copy, please contact us at email@example.com.
Slavery and Human Trafficking Statement – 2023
Jazz Pharmaceuticals plc and its subsidiaries (“Jazz” or “the Company”) are committed to operating our global business with integrity and upholding a high level of ethical conduct among our employees and business partners. We expect that suppliers which provide materials for use in our tangible goods for sale (“Product Suppliers”) to adopt sound human rights practices, to treat workers fairly, with dignity and respect and in all cases to eliminate human trafficking and slavery in their workplace.
Verification: Jazz has existing procedures for assessing our Product Suppliers which include steps for evaluating whether our Product Suppliers comply with applicable laws related to eradication of human trafficking, slavery and illegal child labor. Our Procurement, Supply Chain and Quality Assurance teams oversee these verification procedures. In addition, Jazz has adopted written Standards of Conduct for Supply Chain and will request that our Product Suppliers certify that they comply with applicable laws concerning human trafficking, slavery and illegal child labor in the countries in which they do business.
Audits: Jazz conducts regular, periodic audits of its Product Suppliers to evaluate their compliance with Jazz policies and applicable legal and regulatory requirements. Jazz typically conducts these audits using its own personnel, although it reserves the right to engage independent third-party auditors. Jazz’s current Contract Manufacturer Assessment Guidelines establish procedures for audits of current and potential Product Suppliers, including their training, experience and qualifications, adherence to legal and regulatory requirements, and evaluation of the suppliers’ compliance with quality systems. Jazz tracks any observations and/or non-compliance in its Audit Follow Up & Close-Out procedures to ensure that instances of non-compliance are properly remediated. Jazz has updated its Contract Manufacturer Assessment Guidelines to expressly address human trafficking, slavery and illegal child labor in its auditing protocol.
Materials: Jazz has implemented procedures that require Product Suppliers to certify that materials incorporated into Jazz’s products comply with the laws regarding human trafficking, slavery and illegal child labor in applicable countries.
Accountability Standards: Jazz has established internal accountability standards and procedures, including disciplinary action for its employees and contractors with procurement responsibilities who fail to meet Jazz’s standards regarding identification and elimination of human trafficking, slavery and illegal child labor in its supply chain.
Training: Jazz conducts training for its employees and management who have direct responsibility for supply chain management, particularly with respect to mitigation risks of human trafficking, slavery and illegal child labor within the supply chain.
Jazz Pharmaceuticals has prepared and published its tax strategy in compliance with Schedule 19 to the UK Finance Act 2016.
This page is for U.S. residents only. By clicking on this page, you confirm you are a U.S. resident.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.